Abstract: The present invention provides N-protected isatin compounds of following formula I: wherein X independently represents O, S, NR1; Y represents O, S; R1 represents H, alkyl, aryl; R2 – R8 independently represents H, (CH2)nhalogen, alkyl, (CH2)naryl, (CH2)nOH, (CH2)nSH, (CH2)nOalkyl, (CH2)nSalkyl, (CH2)nOaryl, (CH2)nSaryl, (CH2)nNH2, (CH2)nNHalkyl, (CH2)nN(alkyl)2, (CH2)nNHacyl, (CH2)nCN, (CH2)nNO2, (CH2)nCOOH, (CH2)nCSOH, (CH2)nCOSH, (CH2)nCOOalkyl, (CH2)nCOOaryl, (CH2)nCSOalkyl, (CH2)nCOSaryl, (CH2)nCOSalkyl, (CH2)nCSOaryl, (CH2)nCONH2, (CH2)nCONHalkyl, (CH2)nCON(alkyl)2, , ; n represents 0-15; including pharmaceutically acceptable optica1 and geometrical isomers or salts
Attached
| # | Name | Date |
|---|---|---|
| 1 | 1591-DEL-2011-AbandonedLetter.pdf | 2019-01-17 |
| 1 | Form-3.pdf | 2011-08-21 |
| 2 | 1591-DEL-2011-FER.pdf | 2018-03-19 |
| 2 | Form-1.pdf | 2011-08-21 |
| 3 | 1591-DEL-2011-FER.pdf | 2018-03-19 |
| 3 | Form-1.pdf | 2011-08-21 |
| 4 | 1591-DEL-2011-AbandonedLetter.pdf | 2019-01-17 |
| 4 | Form-3.pdf | 2011-08-21 |
| 1 | 1591DEL2011SS_16-03-2018.pdf |